JD Health International Inc (JDHIF)
3.125
0.00 (0.00%)
USD |
OTCM |
Jan 17, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 9.970B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -37.50% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.298 |
| Price to Book Value | 1.390 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2023, the platform has over 180 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com |
| URL | https://ir.jdhealth.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Consumer Staples |
| Industry | Consumer Staples Distribution & Retail |
| Next Earnings Release | Aug. 15, 2025 (est.) |
| Last Earnings Release | Aug. 15, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2023, the platform has over 180 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com |
| URL | https://ir.jdhealth.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Consumer Staples |
| Industry | Consumer Staples Distribution & Retail |
| Next Earnings Release | Aug. 15, 2025 (est.) |
| Last Earnings Release | Aug. 15, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |